POLIVY

This brand name is authorized in Austria, Canada, Cyprus, Ecuador, Estonia, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, New Zealand, Poland, Romania, United Kingdom, United States

Active ingredients

The drug POLIVY contains one active pharmaceutical ingredient (API):

1 Polatuzumab vedotin UNII KG6VO684Z6 - POLATUZUMAB VEDOTIN

Polatuzumab vedotin is a CD79b-targeted antibody-drug conjugate that preferentially delivers a potent anti-mitotic agent (monomethyl auristatin E, or MMAE) to B-cells, which results in the killing of malignant B-cells. MMAE binds to microtubules and kills dividing cells by inhibiting cell division and inducing apoptosis. Read about Polatuzumab vedotin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
POLIVY Powder for concentrate for solution for infusion	European Medicines Agency (EU)	MPI, EU: SmPC
POLIVY Powder for solution for injection	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L01FX14	Polatuzumab vedotin	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01F Monoclonal antibodies and antibody drug conjugates → L01FX Other monoclonal antibodies
Discover more medicines within L01FX14

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02499614
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 186-MBE-0421, 210-MBE-0821
Country: EE	Ravimiamet	Identifier(s): 1810099, 1834051
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 112212, 471385
Country: FR	Base de données publique des médicaments	Identifier(s): 60380094, 60978348
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 382216, 393295
Country: HK	Department of Health Drug Office	Identifier(s): 66664, 67107
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 8528
Country: IT	Agenzia del Farmaco	Identifier(s): 048443016, 048443028
Country: JP	医薬品医療機器総合機構	Identifier(s): 4291455D1022, 4291455D2029
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1089249, 1091495
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 20697
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100430720, 100456900
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W66558001, W67121001
Country: US	FDA, National Drug Code	Identifier(s): 50242-103, 50242-105